Dana-Farber’s break from Mass General Brigham exposes systemic healthcare consolidation risks and racialized disparities in cancer care access

Indigenous and traditional healing systems view cancer not as an isolated biological event but as a symptom of disrupted relationships—between people, land, and ancestors—often stemming from colonial extraction and environmental harm. Dana-Farber’s expansion, like Mass General Brigham’s consolidation, reflects a biomedical paradigm that treats the body as a site for intervention rather than a node in a larger ecological and social web. The absence of Indigenous knowledge in this narrative reflects a broader erasure of holistic health frameworks that have sustained communities for millennia, even as Western medicine claims to advance ‘cancer care.’

Boston’s healthcare system has been shaped by centuries of racialized urban planning, including the 1950s ‘urban renewal’ projects that displaced Black communities to build institutions like Massachusetts General Hospital. The consolidation of power under Mass General Brigham mirrors Gilded Age monopolies, where elite hospitals operated as de facto public utilities while excluding marginalized patients through discriminatory admissions and pricing. The Affordable Care Act’s market-based reforms further entrenched this model, incentivizing mergers and acquisitions that prioritize shareholder returns over community health needs.

In Kerala, India, the public health system’s emphasis on preventive care and community clinics has reduced cancer mortality rates despite limited resources, contrasting with the U.S. model of hyper-specialized, profit-driven care. In Cuba, a socialist healthcare system prioritizes equitable access to cancer treatment, achieving outcomes comparable to high-income countries while spending a fraction of the U.S. per capita. These models demonstrate that healthcare systems rooted in communal well-being and ecological balance can achieve better outcomes than those prioritizing institutional prestige and financial growth.

Research consistently shows that healthcare consolidation leads to higher costs and reduced access for marginalized communities, with studies documenting how hospital mergers in the U.S. result in price hikes and service reductions in underserved areas. The focus on ‘world-class’ cancer centers like Dana-Farber obscures evidence that community-based care models achieve comparable survival rates for many cancers at lower costs. Additionally, the racialized disparities in cancer outcomes—linked to structural inequities in diagnosis, treatment, and clinical trial participation—are well-documented but rarely addressed in institutional narratives.

Artistic and spiritual traditions often frame illness as a call to collective healing, challenging the biomedical reductionism that treats cancer as a technical problem to be solved by elite institutions. For example, the Black church’s tradition of ‘healing circles’ centers communal support and spiritual resilience in the face of illness, offering a counter-narrative to Dana-Farber’s institutional autonomy. Similarly, Indigenous art and storytelling often depict cancer as a symptom of environmental degradation, linking personal health to land stewardship—a perspective absent from corporate healthcare discourse.

If Dana-Farber’s separation accelerates a trend of elite institutions breaking from consolidated systems, it could further stratify cancer care, leaving safety-net hospitals under-resourced while wealthy patients access cutting-edge treatments. A more equitable future would involve dismantling monopolistic healthcare structures and investing in community-based, publicly funded systems that prioritize prevention and early intervention. Scenario modeling suggests that policies like single-payer healthcare or community land trusts for healthcare facilities could reduce disparities while improving outcomes.

Marginalized patients—particularly Black, Latino, and low-income communities—are systematically excluded from elite cancer care systems through financial barriers, discriminatory practices, and geographic isolation, yet their perspectives are entirely absent from this narrative. Survivors from these communities often report feeling ‘othered’ in elite institutions, where cultural competency is low and treatment decisions are made without their input. The focus on institutional autonomy ignores how these systems perpetuate harm, while the voices of patients who rely on safety-net hospitals are silenced.